Research work · 1995

Frequency of anti‐nuclear antibodies in multiple sclerosis

Susan Barned, Andrew D. Goodman, David H. Mattson

Neurology

Abstract

We found anti-nuclear antibodies (ANA) in 26.7% of 150 relapsing-remitting and in 30.4% of 23 chronic progressive definite multiple sclerosis (MS) patients by retrospective chart review. These patients did not have systemic lupus erythematosus. Since ANA are not pathogenically relevant in MS, they are false-positive, and likely reflect systemic immune dysregulation in MS.

DOI: 10.1212/wnl.45.2.384